# Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar

> **NCT03764527** · PHASE4 · COMPLETED · sponsor: **Professor Anders Björkman** · enrollment: 408 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** Artemether-lumefantrine
- **DRUG:** Coadministered Artesunate plus Amodiaquine

## Key facts

- **NCT ID:** NCT03764527
- **Lead sponsor:** Professor Anders Björkman
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11-01
- **Primary completion:** 2003-02-17
- **Final completion:** 2003-02-17
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2018-12-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764527, "Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03764527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*